UTD2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UTD2, covering 2025-06-13 to 2025-06-13. Get the full timeline:
Most recent: Clinical Trial Update: Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients [Phase 3]